bioAffinity Technologies, Inc.

Bioaffinity Technologies, Inc.

Diagnostics & Research • Healthcare • San Antonio, TX, United States • BIAFW (NCM)

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. It operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.

210 698 5334 3300 Nacogdoches Road, San Antonio, TX 78217, United States

Stock Performance (90 Days)

Data through Dec 17, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

WallachBeth Capital Announces bioAffinity Technologies Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules - PR Newswire
PR Newswire • Oct 8
bioAffinity Technologies Stock Surged A Whopping 79% Today – Here’s An Important Update - Stocktwits
Stocktwits • Sep 25
Bioaffinity Technologies stock soars after lung cancer test aids early detection - Investing.com
Investing.com • Sep 26
$4.8 Million Capital Raise: Cancer Detection Biotech bioAffinity Technologies Completes Public Offering - Stock Titan
Stock Titan • Sep 30
bioAffinity Technologies Reports Record Growth in CyPath® Lung Test Volume for Third Quarter 2025 - Yahoo Finance
Yahoo Finance • Oct 7

Other Diagnostics & Research Companies

View All →
THERMO FISHER SCIENTIFIC INC. logo Thermo Fisher Scientific Inc.
$219.82B market cap
DANAHER CORP /DE/ logo Danaher Corp.
$165.14B market cap
IDEXX LABORATORIES INC /DE logo Idexx Laboratories Inc.
$55.08B market cap
AGILENT TECHNOLOGIES, INC. logo Agilent Technologies, Inc.
$39.23B market cap
IQVIA HOLDINGS INC. logo Iqvia Holdings Inc.
$38.49B market cap
Natera, Inc. logo Natera, Inc.
$32.25B market cap

Frequently Asked Questions

Has bioAffinity Technologies, Inc. had layoffs?
No layoff events have been recorded for bioAffinity Technologies, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does bioAffinity Technologies, Inc. have?
bioAffinity Technologies, Inc. has approximately 57 employees.
What industry is bioAffinity Technologies, Inc. in?
bioAffinity Technologies, Inc. operates in the Diagnostics & Research industry, within the Healthcare sector.
Is bioAffinity Technologies, Inc. a publicly traded company?
Yes, bioAffinity Technologies, Inc. is publicly traded under the ticker symbol BIAFW on the NCM.
Where is bioAffinity Technologies, Inc. headquartered?
bioAffinity Technologies, Inc. is headquartered in San Antonio, TX, United States at 3300 Nacogdoches Road, San Antonio, TX 78217, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.